X-50916021-AG-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PVS1_StrongBS2_Supporting
The ENST00000252677.4(BMP15):βc.596delβ(p.Gly199AspfsTer171) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000024 in 1,210,412 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (β ).
Frequency
Genomes: π 0.000053 ( 0 hom., 2 hem., cov: 22)
Exomes π: 0.000021 ( 0 hom. 12 hem. )
Consequence
BMP15
ENST00000252677.4 frameshift
ENST00000252677.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.397
Genes affected
BMP15 (HGNC:1068): (bone morphogenetic protein 15) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate subunits of a disulfide-linked homodimer, or alternatively, a heterodimer, with the related protein, growth differentiation factor 9 (GDF9). This protein plays a role in oocyte maturation and follicular development, through activation of granulosa cells. Defects in this gene are the cause of ovarian dysgenesis and are associated with premature ovarian failure. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 10 pathogenic variants in the truncated region.
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BMP15 | NM_005448.2 | c.596del | p.Gly199AspfsTer171 | frameshift_variant | 2/2 | ENST00000252677.4 | NP_005439.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BMP15 | ENST00000252677.4 | c.596del | p.Gly199AspfsTer171 | frameshift_variant | 2/2 | 1 | NM_005448.2 | ENSP00000252677 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 6AN: 112189Hom.: 0 Cov.: 22 AF XY: 0.0000583 AC XY: 2AN XY: 34331
GnomAD3 genomes
AF:
AC:
6
AN:
112189
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
34331
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 183391Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67853
GnomAD3 exomes
AF:
AC:
3
AN:
183391
Hom.:
AF XY:
AC XY:
1
AN XY:
67853
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000209 AC: 23AN: 1098223Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 12AN XY: 363585
GnomAD4 exome
AF:
AC:
23
AN:
1098223
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
363585
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000535 AC: 6AN: 112189Hom.: 0 Cov.: 22 AF XY: 0.0000583 AC XY: 2AN XY: 34331
GnomAD4 genome
AF:
AC:
6
AN:
112189
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
34331
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Ovarian dysgenesis 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Sep 12, 2017 | The BMP15 c.596delG (p.Gly199AspfsTer171) variant results in a frameshift and is predicted to result in premature termination of the protein. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. Based on the variant frequency, disease prevalence, disease penetrance, and inheritance mode, this variant could not be ruled out of causing disease. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for ovarian dysgenesis. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at